1. Home
  2. FATN vs MIST Comparison

FATN vs MIST Comparison

Compare FATN & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATN
  • MIST
  • Stock Information
  • Founded
  • FATN 1989
  • MIST 2003
  • Country
  • FATN United States
  • MIST Canada
  • Employees
  • FATN N/A
  • MIST N/A
  • Industry
  • FATN
  • MIST Biotechnology: Pharmaceutical Preparations
  • Sector
  • FATN
  • MIST Health Care
  • Exchange
  • FATN NYSE
  • MIST Nasdaq
  • Market Cap
  • FATN 109.0M
  • MIST 89.8M
  • IPO Year
  • FATN 2025
  • MIST N/A
  • Fundamental
  • Price
  • FATN $8.87
  • MIST $1.60
  • Analyst Decision
  • FATN
  • MIST Strong Buy
  • Analyst Count
  • FATN 0
  • MIST 2
  • Target Price
  • FATN N/A
  • MIST $7.50
  • AVG Volume (30 Days)
  • FATN 39.9K
  • MIST 1.8M
  • Earning Date
  • FATN 01-01-0001
  • MIST 08-07-2025
  • Dividend Yield
  • FATN N/A
  • MIST N/A
  • EPS Growth
  • FATN N/A
  • MIST N/A
  • EPS
  • FATN 0.15
  • MIST N/A
  • Revenue
  • FATN $16,288,881.00
  • MIST N/A
  • Revenue This Year
  • FATN N/A
  • MIST N/A
  • Revenue Next Year
  • FATN N/A
  • MIST N/A
  • P/E Ratio
  • FATN $60.75
  • MIST N/A
  • Revenue Growth
  • FATN N/A
  • MIST N/A
  • 52 Week Low
  • FATN $5.60
  • MIST $0.63
  • 52 Week High
  • FATN $23.27
  • MIST $2.75
  • Technical
  • Relative Strength Index (RSI)
  • FATN N/A
  • MIST 83.15
  • Support Level
  • FATN N/A
  • MIST $1.86
  • Resistance Level
  • FATN N/A
  • MIST $1.97
  • Average True Range (ATR)
  • FATN 0.00
  • MIST 0.14
  • MACD
  • FATN 0.00
  • MIST 0.06
  • Stochastic Oscillator
  • FATN 0.00
  • MIST 100.00

About FATN FATPIPE INC

Fatpipe Inc is a pioneer in enterprise-class, application-aware, secure SD-WAN solutions for organizations, including enterprises, communication service providers, security service providers, government organizations, and other middle-market companies. It is engaged in delivering principal enterprise-class networking software technology. The company is dedicated to continually improving the way organizations connect, ensuring their networks are secure, reliable, and supporting their continued success. Its commitment lies in empowering its customers with a seamless and dependable connectivity infrastructure that safeguards their critical data and fosters business continuity. Further, the company's goal is to ensure its customers have unparalleled insights into their network operations.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: